ALERT: The Rosen Law Firm Announces Investigation Of Investor Securities Claims Against MiMedx Group, Inc. - MDXG

The Rosen Law Firm, P.A. announces that it is investigating potential securities claims against MiMedx Group, Inc. (NASDAQ:MDXG) resulting from reports that the FDA notified the Company that it is unlawfully manufacturing drugs at one of its plants.

The Rosen Law Firm is preparing a securities class action lawsuit on behalf of MiMedx investors to recover investors’ losses. If you purchased or acquired MiMedx on or before September 4, 2013, please go to the website at http://rosenlegal.com for more information. You may also contact Phillip Kim, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com .

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Copyright Business Wire 2010

If you liked this article you might like

Finding Bullish and Bearish Stock Reversals

Finding Bullish and Bearish Stock Reversals

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Merger Buzz Drives Akorn to Top of Health Chart in April

Merger Buzz Drives Akorn to Top of Health Chart in April

MiMedx Group (MDXG) Weak On High Volume

MiMedx Group (MDXG) Weak On High Volume